After a press release from AMAG Pharma (NASDAQ:AMAG) saying they won't be including a "Black Box" warning on their Feraheme drug label, shares in the company have soared by over 14 percent on the day.
Feraheme is the main growth vehicle of the company at this time, and expectations on the Street were they would be hit with a Black Box warning. News they weren't surprised most people and caused them to pour money into the stock.
There are still a lot of questions that Amag will need to answer, but for now it's a probably first step toward turning things slowly around.
AMAG was trading at $16.05, soaring by $2.00, or 14.23 percent at 1:02 PM EST.
No comments:
Post a Comment